89 related articles for article (PubMed ID: 1668563)
1. [Synthesis and analgesic activity of analogs of U-50488, an opiate kappa-agonist].
Ma SC; Yang YL; Yuan XM
Yao Xue Xue Bao; 1991; 26(12):902-5. PubMed ID: 1668563
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and analgesic activity of 3,4-dichloro-N-methyl-N-[trans-2-(1-delta 3-pyrrolinyl)-cyclohexyl]-benzenacetamide hydrochloride].
Ma SC; Lu SN; Li KZ; Wang CQ
Yao Xue Xue Bao; 1986 Nov; 21(11):861-3. PubMed ID: 3035865
[No Abstract] [Full Text] [Related]
3. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
4. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander PF; Lahti RA; Ludens JH
J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and analgesic activity of N-aryl/arylalkyl-N-[2-(1-pyrrolidinyl)cyclohexyl]propanamides.
Essawi MY
Pharmazie; 1999 Jul; 54(7):499-502. PubMed ID: 10445244
[TBL] [Abstract][Full Text] [Related]
6. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor].
Li JG; Ma SC; Lu SN; Wang CQ
Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514
[TBL] [Abstract][Full Text] [Related]
8. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
Piercey MF; Einspahr FJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):267-71. PubMed ID: 2552077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
Paul D; Pick CG; Tive LA; Pasternak GW
J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
[TBL] [Abstract][Full Text] [Related]
10. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
Vonvoigtlander PF; Lewis RA
J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
13. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
14. Kappa opioid analgesia is dependent on serotonergic mechanisms.
Vonvoigtlander PF; Lewis RA; Neff GL
J Pharmacol Exp Ther; 1984 Nov; 231(2):270-4. PubMed ID: 6092612
[TBL] [Abstract][Full Text] [Related]
15. Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain.
Manzanares J; Lookingland KJ; Moore KE
J Pharmacol Exp Ther; 1991 Feb; 256(2):500-5. PubMed ID: 1847197
[TBL] [Abstract][Full Text] [Related]
16. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
Murray CW; Cowan A
J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
[TBL] [Abstract][Full Text] [Related]
17. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
Castillo R; Kissin I; Bradley EL
Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
[TBL] [Abstract][Full Text] [Related]
18. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
19. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.
Belkowski SM; Alicea C; Eisenstein TK; Adler MW; Rogers TJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1491-6. PubMed ID: 7791124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
